A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis

Authors

Jairam Krishnamurthy, University of Nebraska Medical Center
Jingqin Luo, Washington University School of Medicine in St. Louis
Rama Suresh, Washington University School of Medicine in St. Louis
Foluso Ademuyiwa, Washington University School of Medicine in St. Louis
Caron Rigden, Washington University School of Medicine in St. Louis
Timothy Rearden, Washington University School of Medicine in St. Louis
Katherine Clifton, Washington University School of Medicine in St. Louis
Katherine Weilbaecher, Washington University School of Medicine in St. Louis
Ashley Frith, Washington University School of Medicine in St. Louis
Anna Roshal, Washington University School of Medicine in St. Louis
Mathew Cherian, Washington University School of Medicine in St. Louis
Tracy Summa, Washington University School of Medicine in St. Louis
Brittney Haas, Washington University School of Medicine in St. Louis
Shana Thomas, Washington University School of Medicine in St. Louis
Leonel Hernandez-Aya, Washington University School of Medicine in St. Louis
Lindsey Peterson, Washington University School of Medicine in St. Louis
Cynthia X Ma, Washington University School of Medicine in St. Louis
et al

Journal

NPJ Breast Cancer

Publication Date

3-21-2022

Volume

8

Issue

1

First Page

35

Document Type

Open Access Publication

DOI

10.1038/s41523-022-00399-w

Rights and Permissions

Krishnamurthy J, Luo J, Suresh R, Ademuyiwa F, Rigden C, Rearden T, Clifton K, Weilbaecher K, Frith A, Roshal A, Tandra PK, Cherian M, Summa T, Haas B, Thomas S, Hernandez-Aya L, Bergqvist M, Peterson L, Ma CX. A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis. NPJ Breast Cancer. 2022 Mar 21;8(1):35. doi: 10.1038/s41523-022-00399-w. https://www.nature.com/articles/s41523-022-00399-w This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Krishnamurthy, Jairam; Luo, Jingqin; Suresh, Rama; Ademuyiwa, Foluso; Rigden, Caron; Rearden, Timothy; Clifton, Katherine; Weilbaecher, Katherine; Frith, Ashley; Roshal, Anna; Cherian, Mathew; Summa, Tracy; Haas, Brittney; Thomas, Shana; Hernandez-Aya, Leonel; Peterson, Lindsey; Ma, Cynthia X; and et al, "A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis." NPJ Breast Cancer. 8, 1. 35 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11464